These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22760006)

  • 1. The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice.
    Hing TC; Ho S; Shih DQ; Ichikawa R; Cheng M; Chen J; Chen X; Law I; Najarian R; Kelly CP; Gallo RL; Targan SR; Pothoulakis C; Koon HW
    Gut; 2013 Sep; 62(9):1295-305. PubMed ID: 22760006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
    Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine deaminase inhibition prevents Clostridium difficile toxin A-induced enteritis in mice.
    de Araújo Junqueira AF; Dias AA; Vale ML; Spilborghs GM; Bossa AS; Lima BB; Carvalho AF; Guerrant RL; Ribeiro RA; Brito GA
    Infect Immun; 2011 Feb; 79(2):653-62. PubMed ID: 21115723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The American Cockroach Peptide Periplanetasin-2 Blocks
    Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
    J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
    [No Abstract]   [Full Text] [Related]  

  • 5. Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis.
    Ishida Y; Maegawa T; Kondo T; Kimura A; Iwakura Y; Nakamura S; Mukaida N
    J Immunol; 2004 Mar; 172(5):3018-25. PubMed ID: 14978106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity.
    Koon HW; Wang J; Mussatto CC; Ortiz C; Lee EC; Tran DH; Chen X; Kelly CP; Pothoulakis C
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038278
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice.
    McDermott AJ; Higdon KE; Muraglia R; Erb-Downward JR; Falkowski NR; McDonald RA; Young VB; Huffnagle GB
    Immunology; 2015 Apr; 144(4):704-16. PubMed ID: 25399934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of neutral endopeptidase exacerbates intestinal inflammation induced by Clostridium difficile toxin A.
    Kirkwood KS; Bunnett NW; Maa J; Castagliolo I; Liu B; Gerard N; Zacks J; Pothoulakis C; Grady EF
    Am J Physiol Gastrointest Liver Physiol; 2001 Aug; 281(2):G544-51. PubMed ID: 11447035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications for immunotherapy of
    Xu B; Wu X; Gong Y; Cao J
    Gut Microbes; 2021; 13(1):1968258. PubMed ID: 34432564
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis.
    Yoo JH; Ho S; Tran DH; Cheng M; Bakirtzi K; Kukota Y; Ichikawa R; Su B; Tran DH; Hing TC; Chang I; Shih DQ; Issacson RE; Gallo RL; Fiocchi C; Pothoulakis C; Koon HW
    Cell Mol Gastroenterol Hepatol; 2015 Jan; 1(1):55-74.e1. PubMed ID: 25729764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis.
    Cavalcante IC; Castro MV; Barreto AR; Sullivan GW; Vale M; Almeida PR; Linden J; Rieger JM; Cunha FQ; Guerrant RL; Ribeiro RA; Brito GA
    Infect Immun; 2006 May; 74(5):2606-12. PubMed ID: 16622196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
    Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
    Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury.
    Chae S; Eckmann L; Miyamoto Y; Pothoulakis C; Karin M; Kagnoff MF
    J Immunol; 2006 Jul; 177(2):1214-20. PubMed ID: 16818780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.
    Warren CA; Li Y; Calabrese GM; Freire RS; Zaja-Milatovic S; van Opstal E; Figler RA; Linden J; Guerrant RL
    Infect Immun; 2012 Dec; 80(12):4463-73. PubMed ID: 23045479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis.
    Cottrell GS; Amadesi S; Pikios S; Camerer E; Willardsen JA; Murphy BR; Caughey GH; Wolters PJ; Coughlin SR; Peterson A; Knecht W; Pothoulakis C; Bunnett NW; Grady EF
    Gastroenterology; 2007 Jun; 132(7):2422-37. PubMed ID: 17570216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
    Koon HW; Shih DQ; Hing TC; Yoo JH; Ho S; Chen X; Kelly CP; Targan SR; Pothoulakis C
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis.
    Castagliuolo I; Riegler M; Pasha A; Nikulasson S; Lu B; Gerard C; Gerard NP; Pothoulakis C
    J Clin Invest; 1998 Apr; 101(8):1547-50. PubMed ID: 9541482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local injection of dsRNA targeting calcitonin receptor-like receptor (CLR) ameliorates Clostridium difficile toxin A-induced ileitis.
    Bhargava A; Clifton MS; Mhaske P; Liao M; Pothoulakis C; Leeman SE; Grady EF
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):731-6. PubMed ID: 23267070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-11 inhibits Clostridium difficile toxin A enterotoxicity in rat ileum.
    Castagliuolo I; Kelly CP; Qiu BS; Nikulasson ST; LaMont JT; Pothoulakis C
    Am J Physiol; 1997 Aug; 273(2 Pt 1):G333-41. PubMed ID: 9277411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
    Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
    World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.